Joerg Berghausen

Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase

Vito Guagnano, Pascal Furet, Carsten Spanka et al. · Journal of Medicinal Chemistry · 2011 · 484 citations · Full text

Pharmaceutical Chemistry, Tumor Biology, Medicinal Chemistry +19

Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors

Philipp Holzer, Keiichi Masuya, Pascal Furet et al. · Journal of Medicinal Chemistry · 2015 · 202 citations · Full text

Dihydroisoquinolinone Derivative, Drug Target, Molecular Biology +18

Polymorphism - integrated approach from high-throughput screening to crystallization optimization

Rolf Hilfiker, Joerg Berghausen, Fritz Blatter et al. · Journal of Thermal Analysis and Calorimetry · 2003 · 72 citations

Accelerated Formulation Development for Nanomilled Active Pharmaceutical Ingredients Using a Screening Approach

Michael Juhnke, Joerg Berghausen, Carsten Timpe · Chemical Engineering & Technology · 2010 · 54 citations

Nanoparticles, Nanotherapeutics, Engineering +23

Modulation of Oral Bioavailability and Metabolism for Closely Related Cyclic Hexapeptides

Thomas Vorherr, Ian Lewis, Joerg Berghausen et al. · International Journal of Peptide Research and Therapeutics · 2017 · 27 citations · Full text